Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Incheon, South Korea, 1997-2001 cases followed-up until 2002)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C01-02Tongue5061.547.140.663.049.844.244.752.0
C03-06Oral cavity6461.848.745.563.552.450.751.354.4
C07-08Salivary gland4986.370.563.387.974.469.366.969.7
C09Tonsil2774.147.940.575.850.944.542.348.4
C11Nasopharynx7477.056.553.577.757.955.945.253.6
C12-13Hypopharynx5160.841.829.162.545.032.737.138.3
C15Oesophagus30439.920.417.741.122.421.321.725.9
C16Stomach429361.246.741.962.749.947.042.950.0
C17Small intestine8151.240.834.152.543.437.534.647.7
C18Colon112069.654.748.771.458.654.549.557.4
C19-20Rectum112277.758.749.679.462.655.446.757.6
C22Liver232832.418.614.933.019.616.316.016.8
C23-24Gall bladder50639.321.717.540.523.720.322.525.3
C25Pancreas51821.911.911.022.512.712.311.314.2
C30-31Nose/Sinuses5076.963.156.578.667.462.673.963.4
C32Larynx22265.253.548.167.058.055.255.561.6
C33-34Lung256634.017.515.535.219.118.318.420.6
C37-38Other thoracic organs5654.538.330.755.741.034.231.232.5
C40-41Bone10473.967.259.974.969.163.043.246.9
C43Melanoma skin4580.064.064.081.668.372.571.071.5
C44Other skin26485.974.069.788.881.783.383.085.4
C47+C49Connective tissue13580.467.455.181.469.658.553.555.6
C48Peritoneum5454.435.730.055.737.833.431.128.4
C50Breast144591.382.677.391.883.979.374.378.5
C53Cervix129890.181.576.390.883.178.973.879.5
C54Corpus uteri14089.385.080.290.087.083.682.272.3
C55Uterus unspecified3314.914.914.915.215.315.419.126.2
C56Ovary39078.365.758.079.167.260.352.758.7
C61Prostate28278.658.150.482.967.965.563.569.4
C62Testis29100.096.196.1100.397.197.798.398.3
C64Kidney27974.765.161.176.268.766.964.467.9
C65Renal pelvis3482.463.947.984.168.053.261.472.3
C66Ureter3376.569.869.879.077.283.387.291.0
C67Urinary bladder46778.065.560.180.772.171.065.976.1
C70-72Brain & nervous system33356.543.738.557.244.940.039.641.0
C73Thyroid71293.891.589.494.593.392.290.092.6
C74Adrenal gland3075.054.854.875.455.556.186.178.4
C81Hodgkin lymphoma2885.781.381.386.382.683.281.182.8
C82-85+C96Non-Hodgkin lymphoma48370.353.050.971.455.254.253.857.4
C90Multiple myeloma8956.233.725.357.335.928.427.229.0
C91Lymphoid leukaemia12567.250.250.267.550.750.838.140.3
C92-94Myeloid leukaemia25062.642.438.363.143.439.938.836.0


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table2b: Number and proportion of cases by vital status and median follow-up (in months) by site (Incheon, Korea, 1997-2001 cases followed-up until 2002)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Incheon, South Korea, 1997-2001 cases followed-up until 2002)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Incheon, South Korea, 1997-2001 cases followed-up until 2002)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)